ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of May 19, 2026, CLPT trades at $11.15 with a market cap of $349.08M and a P/E ratio of -15.82. CLPT moved -4.55% today. Year to date, CLPT is -20.67%; over the trailing twelve months it is -15.55%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes CLPT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $11.15 |
| Market Cap | $349.08M |
| P/E Ratio | -15.82 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.10 |
| 52-Week Low | $8.27 |
| Volume | 35 |
| Avg Volume | 0 |
| Revenue (TTM) | $31.39M |
| Net Income | $-18.91M |
| Gross Margin | 60.92% |
3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.